Profile data is unavailable for this security.
About the company
Alphamab Oncology is an investment holding company primarily engaged in the biopharmaceutical business. The Company is a full-industry chain enterprise specializing in research, development, manufacture, and commercialization of innovative tumor immunobiology macromolecular targeted drugs. The Company has bio-innovation drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. The Company operates its businesses in both domestic and overseas markets.
- Revenue in HKD (TTM)235.83m
- Net income in HKD-227.01m
- Incorporated2018
- Employees435.00
- LocationAlphamab OncologyNo. 175Fangzhou Road, Suzhou Industrial ParkSuzhou 215125ChinaCHN
- Phone+86 51 262850800
- Websitehttps://www.alphamabonc.com/en/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
China Isotope & Radiation Corp | 7.15bn | 399.88m | 3.53bn | 3.11k | 8.82 | 0.6968 | 3.26 | 0.4929 | 1.25 | 1.25 | 22.36 | 15.82 | 0.5312 | 4.22 | 1.84 | 2,303,436.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 28.27 | 7.82 | 15.35 | -5.43 | 2.88 | 3.63 | 2.92 |
CARsgen Therapeutics Holdings Ltd | 0.00 | -806.08m | 3.81bn | 516.00 | -- | 1.96 | -- | -- | -1.45 | -1.45 | 0.00 | 3.37 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
Biocytogen Pharmaceuticals Beijng Co Ltd | 772.79m | -412.80m | 3.85bn | 1.07k | -- | 4.54 | -- | 4.98 | -1.04 | -1.04 | 1.94 | 2.12 | 0.2732 | 16.21 | 5.74 | 724,946.70 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 3.89bn | 1.93k | 226.26 | 0.9292 | 34.33 | 0.7313 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
Jiangsu Recbio Technology Co Ltd | 0.00 | -616.54m | 4.34bn | 472.00 | -- | 3.73 | -- | -- | -1.28 | -1.28 | 0.00 | 2.41 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
Alphamab Oncology | 235.83m | -227.01m | 4.71bn | 435.00 | -- | 2.61 | -- | 19.97 | -0.2361 | -0.2361 | 0.2457 | 1.87 | 0.1028 | 0.7705 | 19.34 | 542,130.60 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
Ocumension Therapeutics | 265.57m | -409.39m | 4.76bn | 444.00 | -- | 1.50 | -- | 17.94 | -0.6309 | -0.6309 | 0.4091 | 4.56 | 0.078 | 3.61 | 2.12 | 598,131.90 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
Shandong Boan Biotechnology Co Ltd | 666.31m | -128.68m | 4.95bn | 813.00 | -- | 3.48 | -- | 7.42 | -0.2527 | -0.2527 | 1.31 | 2.79 | 0.2732 | 1.35 | 2.53 | 819,569.90 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
Beijing Luzhu Biotechnology Co Ltd | 0.00 | -268.79m | 4.96bn | 133.00 | -- | 4.51 | -- | -- | -1.34 | -1.34 | 0.00 | 5.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
Microport NeuroTech Ltd | -100.00bn | -100.00bn | 5.24bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.49bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
Consun Pharmaceutical Group Ltd | 2.79bn | 845.69m | 5.53bn | 3.13k | 6.39 | 1.40 | 5.94 | 1.98 | 1.06 | 1.06 | 3.49 | 4.82 | 0.4981 | 2.08 | 9.10 | 892,870.80 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.23m | 5.60bn | 2.87k | -- | 1.17 | -- | 2.79 | -0.0063 | -0.0063 | 0.2157 | 0.5121 | 0.1572 | 0.8101 | 4.72 | 698,315.60 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
Ascentage Pharma Group International | 239.29m | -997.79m | 5.71bn | 583.00 | -- | 87.60 | -- | 23.84 | -3.52 | -3.52 | 0.8476 | 0.2244 | 0.0833 | 2.38 | 2.22 | 410,440.80 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
Qyuns Therapeutics Co Ltd | 0.00 | -547.33m | 6.30bn | 331.00 | -- | 19.81 | -- | -- | -2.46 | -2.46 | 0.00 | 1.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64 | -69.52 | 0.5349 | -- | -- | -- | -70.28 | -- | -- | -- |
New Horizon Health Ltd | 1.47bn | 119.25m | 6.47bn | 1.04k | 59.26 | 2.01 | 41.68 | 4.41 | 0.2386 | 0.2386 | 3.22 | 7.03 | 0.4536 | 2.16 | 2.08 | 1,672,148.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
Data as of May 23 2024. Currency figures normalised to Alphamab Oncology's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 09 May 2024 | 23.84m | 2.47% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 19.62m | 2.03% |
First Seafront Fund Management Co., Ltd.as of 31 Dec 2023 | 7.54m | 0.78% |
BlackRock Fund Advisorsas of 09 May 2024 | 6.49m | 0.67% |
Essence Fund Co., Ltd.as of 30 Jun 2023 | 3.50m | 0.36% |
Bosera Asset Management Co., Ltd.as of 30 Jun 2023 | 3.31m | 0.34% |
Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 2.97m | 0.31% |
E Fund Management Co., Ltd.as of 30 Jun 2023 | 2.38m | 0.25% |
BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 1.74m | 0.18% |
China Asset Management Co., Ltd.as of 30 Jun 2023 | 1.00m | 0.10% |
More ▼
Data from 31 Dec 2023 - 16 May 2024Source: FactSet Research Systems Inc.